Additional Effects of Transversus Abdominial Strengthening Along With Pelvic Floor Muscle Strengthening on Stress Urinary Incontinence Among Multiparous Women

November 28, 2024 updated by: Foundation University Islamabad
SUI stands for stress urinary incontinence. A common condition seen among multiparous women associated with physical strain like bending, coughing, sneezing that put strain on the pelvic floor muscles.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 460000
        • Foundation University College of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age group: multiparous women ( 30-50 yrs)
  • females only
  • all modes of delivery of childbirth
  • diagnosed cases of SUI from fauji foundation hospital.
  • patient without any medical contraindications and limitations (Sign and Symptoms of SUI)
  • accordances with the michigan incontinence index

Exclusion Criteria:

  • pregnancy or recent childbirth
  • any history of pelvic organ prolapse or surgical intervention
  • metabolic diseases, uncontrolled hypertension as well as neurological intervention
  • any kind of malignancy in lower abdomen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: pelvic floor strengthening group

Group A that is the control group will includes pelvic floor strengthening exercises. given three times a week on alternate days and session will be given for 4 weeks (protocol) and the retention effect will be given for 8 weeks. Each session will be performed at a moderate intensity , indicated by sustained contractions for 5 seconds initially and then progresively increased to 10 seconds overtime.

pelvic floor strengtheing exercises includes :

  1. breathing exercises,
  2. kegels exercises
  3. bridging exercises
  4. squatting
  5. Elevator exercises

pelvic floor strengthening exercises includes :

  1. breathing exercises,
  2. kegels exercises
  3. bridging exercises
  4. squatting
  5. Elevator exercises
Experimental: PFMS + Transversus abdominal strengthening
group B includes interventional group which includes core stabilization exercises for 2 weeks like stomach hallowing , dead bugs and pelvic tilt exercises and after 2 weeks dead bug progression, planks and pelvic floor strengthening exercises.

pelvic floor strengthening exercises includes :

  1. breathing exercises,
  2. kegels exercises
  3. bridging exercises
  4. squatting
  5. Elevator exercises
core stabilization exercises for 2 weeks like stomach hallowing , dead bugs and pelvic tilt exercises and after 2 weeks dead bug progression, planks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stress urinary incontinence
Time Frame: 8 weeks
SUI will be measured using Michigan incontinence index
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2024

Primary Completion (Actual)

November 10, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

November 28, 2024

First Submitted That Met QC Criteria

November 28, 2024

First Posted (Estimated)

December 4, 2024

Study Record Updates

Last Update Posted (Estimated)

December 4, 2024

Last Update Submitted That Met QC Criteria

November 28, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence

Clinical Trials on pelvic floor strengthening

Subscribe